Jan J. Jobsen

10.5k total citations · 3 hit papers
92 papers, 6.4k citations indexed

About

Jan J. Jobsen is a scholar working on Obstetrics and Gynecology, Cancer Research and Oncology. According to data from OpenAlex, Jan J. Jobsen has authored 92 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Obstetrics and Gynecology, 32 papers in Cancer Research and 27 papers in Oncology. Recurrent topics in Jan J. Jobsen's work include Endometrial and Cervical Cancer Treatments (45 papers), Breast Cancer Treatment Studies (31 papers) and Ovarian cancer diagnosis and treatment (19 papers). Jan J. Jobsen is often cited by papers focused on Endometrial and Cervical Cancer Treatments (45 papers), Breast Cancer Treatment Studies (31 papers) and Ovarian cancer diagnosis and treatment (19 papers). Jan J. Jobsen collaborates with scholars based in Netherlands, United Kingdom and France. Jan J. Jobsen's co-authors include Carien L. Creutzberg, Ludy Lutgens, Carla C. Wárlám-Rodenhuis, Marnix L.M. Lybeert, Remi A. Nout, P. Koper, Vincent T.H.B.M. Smit, H Beerman, M. van Lent and Elzbieta M. van der Steen‐Banasik and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jan J. Jobsen

91 papers receiving 6.3k citations

Hit Papers

Surgery and postoperative... 2000 2026 2008 2017 2000 2016 2015 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial
    2000 1.3k citations Carien L. Creutzberg, P. Koper et al. profile →
  2. Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
    2016 569 citations Ellen Stelloo, Remi A. Nout et al. Clinical Cancer Research profile →
  3. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trials
    2015 267 citations Tjalling Bosse, Elke E.M. Peters et al. European Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan J. Jobsen Netherlands 35 4.3k 3.1k 1.4k 1.1k 1.1k 92 6.4k
Matthew A. Powell United States 40 3.3k 0.8× 2.4k 0.8× 747 0.5× 1.1k 1.0× 837 0.8× 182 5.7k
Carla C. Wárlám-Rodenhuis Netherlands 22 2.4k 0.6× 1.9k 0.6× 1.4k 1.0× 893 0.8× 1.2k 1.2× 35 4.9k
Vicky Makker United States 34 2.0k 0.5× 1.5k 0.5× 671 0.5× 1.9k 1.7× 592 0.6× 180 4.6k
Catherine Uzan France 33 1.7k 0.4× 2.2k 0.7× 468 0.3× 779 0.7× 953 0.9× 204 3.9k
Alessandro Buda Italy 32 2.8k 0.6× 2.1k 0.7× 409 0.3× 796 0.7× 1.2k 1.1× 111 4.4k
Revathy B. Iyer United States 35 1.7k 0.4× 1.4k 0.4× 394 0.3× 765 0.7× 1.5k 1.4× 108 4.0k
Mitchell Morris United States 34 4.1k 1.0× 2.0k 0.6× 230 0.2× 1.1k 1.0× 2.7k 2.5× 73 5.8k
Francis J. Major United States 20 3.2k 0.7× 2.3k 0.7× 224 0.2× 694 0.6× 1.1k 1.1× 34 4.4k
Rachelle Lanciano United States 37 2.3k 0.5× 973 0.3× 255 0.2× 939 0.8× 1.6k 1.5× 109 4.1k
Annamaria Ferrero Italy 32 935 0.2× 1.4k 0.4× 429 0.3× 1.2k 1.0× 1.2k 1.1× 168 3.4k

Countries citing papers authored by Jan J. Jobsen

Since Specialization
Citations

This map shows the geographic impact of Jan J. Jobsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan J. Jobsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan J. Jobsen more than expected).

Fields of papers citing papers by Jan J. Jobsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan J. Jobsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan J. Jobsen. The network helps show where Jan J. Jobsen may publish in the future.

Co-authorship network of co-authors of Jan J. Jobsen

This figure shows the co-authorship network connecting the top 25 collaborators of Jan J. Jobsen. A scholar is included among the top collaborators of Jan J. Jobsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan J. Jobsen. Jan J. Jobsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vermij, Lisa, Alicia León‐Castillo, Melanie Powell, et al.. (2024). Clinical and Molecular Characteristics of High-Risk, Recurrent, or Metastatic Endometrial Cancer That Is Human Epidermal Growth Factor Receptor 2–Low. Journal of Clinical Oncology. 43(4). 443–452. 3 indexed citations
2.
Petr, Jan, Evelyn M. Monninkhof, Mirjam I. Geerlings, et al.. (2023). Effect of Physical Exercise on MRI‐Assessed Brain Perfusion in Chemotherapy‐Treated Breast Cancer Patients: A Randomized Controlled Trial. Journal of Magnetic Resonance Imaging. 59(5). 1667–1680. 1 indexed citations
3.
Vermij, Lisa, Jan J. Jobsen, Mariël Brinkhuis, et al.. (2022). 2022-RA-568-ESGO Prognostic Relevance of FIGO grading is Limited to NSMP Endometrial Cancers. International Journal of Gynecological Cancer. 32. A97–A98. 1 indexed citations
4.
Boer, Stephanie M. de, Melanie Powell, Alexandra Léary, et al.. (2022). 2022-RA-825-ESGO The impact of age on prognosis in women with endometrial cancer: a pooled analysis of the PORTEC-1, -2 and -3 randomised trials. International Journal of Gynecological Cancer. 32. A113–A113. 1 indexed citations
5.
Horeweg, Nanda, Remi A. Nout, Ellen Stelloo, et al.. (2022). 2022-RA-450-ESGO Benefit of adjuvant radiotherapy depends on molecular class of early-stage endometrial cancer. International Journal of Gynecological Cancer. 32. A95–A96. 1 indexed citations
6.
Vermij, Lisa, Hein Putter, Jan J. Jobsen, et al.. (2022). 2022-RA-925-ESGO Development of adjuvant treatment decision support tool for endometrial cancer patients by pooled analysis of data from 2000 women included in the PORTEC-1–3 trials and a prospective cohort study. International Journal of Gynecological Cancer. 32. A119–A120. 1 indexed citations
7.
Peters, Elke E.M., Alicia León‐Castillo, Vincent T.H.B.M. Smit, et al.. (2021). Defining Substantial Lymphovascular Space Invasion in Endometrial Cancer. International Journal of Gynecological Pathology. 41(3). 220–226. 47 indexed citations
8.
Horeweg, Nanda, Marco de Bruyn, Remi A. Nout, et al.. (2020). Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer. Cancer Immunology Research. 8(12). 1508–1519. 42 indexed citations
9.
Witlox, Lenja, Sanne B. Schagen, Michiel B. de Ruiter, et al.. (2019). Effect of physical exercise on cognitive function and brain measures after chemotherapy in patients with breast cancer (PAM study): protocol of a randomised controlled trial. BMJ Open. 9(6). e028117–e028117. 21 indexed citations
10.
Schreuder, K., Mieke J. Aarts, J. W. S. Merkus, et al.. (2019). An actualised population‐based study on the use of radiotherapy in breast cancer patients in the Netherlands. The Breast Journal. 25(5). 942–947. 10 indexed citations
11.
Wortman, Bastiaan G., Carien L. Creutzberg, Hein Putter, et al.. (2018). Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy. British Journal of Cancer. 119(9). 1067–1074. 163 indexed citations
12.
Stelloo, Ellen, Remi A. Nout, Elisabeth M. Osse, et al.. (2016). Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts. Clinical Cancer Research. 22(16). 4215–4224. 569 indexed citations breakdown →
13.
Church, David N., Ellen Stelloo, Remi A. Nout, et al.. (2014). Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer. JNCI Journal of the National Cancer Institute. 107(1). 402–402. 241 indexed citations
14.
Jobsen, Jan J., et al.. (2014). Pattern of Ipsilateral Breast Tumor Recurrence After Breast-Conserving Therapy. International Journal of Radiation Oncology*Biology*Physics. 89(5). 1006–1014. 24 indexed citations
15.
Nout, Remi A., Hein Putter, Ina M. Jürgenliemk‐Schulz, et al.. (2011). Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data. European Journal of Cancer. 48(11). 1638–1648. 114 indexed citations
16.
Creutzberg, Carien L., Remi A. Nout, Marnix L.M. Lybeert, et al.. (2011). Fifteen-Year Radiotherapy Outcomes of the Randomized PORTEC-1 Trial for Endometrial Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 81(4). e631–e638. 227 indexed citations
17.
Struikmans, H., Mieke J. Aarts, Jan J. Jobsen, et al.. (2011). An increased utilisation rate and better compliance to guidelines for primary radiotherapy for breast cancer from 1997 till 2008: A population-based study in The Netherlands. Radiotherapy and Oncology. 100(2). 320–325. 21 indexed citations
18.
Siesling, Sabine, Lonneke V. van de Poll‐Franse, Jan J. Jobsen, O.J. Repelaer van Driel, & Adri C. Voogd. (2007). Explanatory factors for variation in the use of breast conserving surgery and radiotherapy in the Netherlands, 1990–2001. The Breast. 16(6). 606–614. 22 indexed citations
19.
Franckena, Martine, Lukas J.A. Stalpers, P. Koper, et al.. (2007). Long-Term Improvement in Treatment Outcome After Radiotherapy and Hyperthermia in Locoregionally Advanced Cervix Cancer: An Update of the Dutch Deep Hyperthermia Trial. International Journal of Radiation Oncology*Biology*Physics. 70(4). 1176–1182. 149 indexed citations
20.
Voogd, Adri C., Emiel J. Rutgers, Paula H.M. Elkhuizen, et al.. (2005). Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. European Journal of Cancer. 41(17). 2637–2644. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew A. Powell Breakdown of academic impact, for papers by Carla C. Wárlám-Rodenhuis Breakdown of academic impact, for papers by Vicky Makker Breakdown of academic impact, for papers by Catherine Uzan Breakdown of academic impact, for papers by Alessandro Buda Breakdown of academic impact, for papers by Revathy B. Iyer Breakdown of academic impact, for papers by Mitchell Morris Breakdown of academic impact, for papers by Francis J. Major Breakdown of academic impact, for papers by Rachelle Lanciano Breakdown of academic impact, for papers by Annamaria Ferrero
Rankless by CCL
2026